PUBLISHED DATE : Jun 2023 | Pages : 232
Fill out your details & get your free sample
The Biosafety Cabinet Market Size, Share, & Trends Analysis Report by
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2023–2028.
232 Pages
82 Tables
103 Charts
5 Regions
16 Countries
16 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 405.86 Million |
| Market Size (2022) | USD 265 Million |
| CAGR (2022-2028) | 7.36% |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segments | Product Type, End-User, Distribution Channel, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY PLAYERS | Thermo Fisher, Kewaunee Scientific, and Esco Lifesciences Group |
The global biological safety cabinet market size was valued at USD 265 million in 2022 and is expected to reach USD 405.86 million by 2028, growing at a CAGR of 7.36% during the forecast period. The biosafety cabinets have various usages across industries such as the pharmaceutical industry, academic research institutes and research institutes, diagnostic laboratories, and the biotechnological sector. However, the biosafety cabinet market has major significance in the pharmaceutical industry as they require the utmost safety in creating new formulas for a particular medicine development. They also use biosafety cabinets to test their products on microorganisms and viruses to ensure the efficiency of their medicines is high.
Different laboratories with different biosafety levels mean a wide range of biosafety cabinets are available in the market. The operational laboratories choose the biosafety cabinets also based on the type of sample that they are dealing with. As samples can be hazardous various levels of safety will have to be followed. The class I safety cabinets are used at diagnostics laboratories carrying blood, bodily fluids, stool, and urine tests. As these cabinets provide safety for the environment and the operator and these samples can be of lower risk levels, the usage of Class I is highly concentrated in this segment. The Class II biosafety cabinets have the majority share in the biosafety cabinet market as they have a wide variety of sub-segments that can handle the sample safely towards the operator, sample, and environment. The class III biosafety cabinets are used at facilities where biosafety level 4 must be followed.
The effects of the pandemic highlighted the importance of hygiene and a controlled environment required to protect operators, samples, and the environment from hazardous materials and the effects of these elements on the environment. The growth of the biosafety cabinet market is propelled due to the increase in communicable and infectious diseases. This has helped to increase attempts to find medications, thus requiring a biosafety cabinet during the procedure. Furthermore, based on the biosafety level of the lab, there are regulations in place by various agencies that have regulated rules that must be adhered to prevent any leakage or contamination of the samples across these labs that can be hazardous.
The Growth in Technological Advancements
With huge advancements in the technology sector, the biosafety cabinet market is also being integrated with technologies that can help detect any leakages or failures of any part of the cabinets. Over the past years, there have been huge developments in the technological integration with these biosafety cabinets. Technological developments such as HEPA filtration systems can filter out 99.9% of the contaminants in the air. These systems have also been integrated with IOT, such as automotive systems shut down and alarm systems that will raise alarms if these systems observe any malfunction or failure of the exhaust systems.
Increased Risk of Communal Diseases
The world has recently witnessed the catastrophe that communicable diseases can cause through the Covid-19 virus. A disease that can be spread from one person to another through various ways, including contact with another person’s blood and bodily fluids or breathing in airborne viruses, and being bitten by an insect carrying the pathogen or virus is called a communicable or infectious disease. These diseases can have a variety of severity ranging from asymptomatic (no symptoms) to severe to fatal. Some examples of communicable diseases are HIV, hepatitis A, B, and C, measles, salmonella, and blood-borne diseases. The biosafety cabinets are used in laboratories to study the organisms that transmit such diseases and could be the cause of the spread of communal diseases. Since these pathogens are infectious and can easily spread, utmost care must be taken to handle them. Hence biosafety cabinets are a must in such cases. These cabinets also allow the researchers to analyze the functioning and the process of infection that these organisms inflict.
Development in Biological Testing
The world is currently moving towards modernization and an advanced technological era. These advancements in technology have allowed chemical, biological, and microbiological testing. Further, these tests are conducted to understand and conduct analysis or research on the parameters of a product/subject. The subject in biological testing can be a human, dead or alive, animals and birds. Growing importance is given to biological testing as it is crucial in the early and timely diagnostics of infectious diseases and helps properly manage patients. Biological testing is carried out with substances that can harm the environment and humans, which can also potentially cause infections among them. Hence, such reasons are driving the growth of biological testing facilities across the globe, which will positively impact the biosafety cabinet market as they would be an integral part of the laboratories handling such samples.
INSIGHTS BY PRODUCT TYPE
The biosafety cabinets or biological safety cabinets are of three major types Class I, II, III. They are assigned to various classes based on the level of safety and protection offered and the level of biosafety measures it can operate. Class II is further sub-segmented into five subcategories. The sub-segments have advanced features such as HEPA filtration systems; they regulate airflow pressure and are safer than class I biosafety cabinets. Class II held most of the global biosafety cabinet market share as they are versatile and used across most facilities.
Class II is the majorly used in the global biosafety cabinet market as it is economically more affordable and safer than Class I. The Class II biosafety cabinets can be used across biosafety levels 1 to 3. Hence this class of biosafety cabinets has wider applications. The Class III biosafety cabinets are used majorly across pharmaceutical laboratories as they require the highest level of safety.
INSIGHTS BY END-USER
The global biological safety cabinet market is driven by the safety requirement when handling hazardous substances across various sectors, such as pharmaceutical and biopharmaceuticals, academic research institutes, and diagnostic laboratories. The biosafety cabinets play a critical role in these sectors, enabling them to carry out tests and procedures without contamination. Research institutes are of two types private and university. Both play a very important role in finding new drug compositions and new techniques for diagnostic purposes for various diseases. Pharmaceutical and biopharmaceutical sectors had the majority share of the global biosafety cabinet market, accounting for over 53%. The biotechnology sector is propelling the industry’s growth as it is heavily involved with researching and developing therapeutic proteins and drugs through genetic engineering. This sector is important for integrating biology and technology to change or improve a component, or entire biological system, which can benefit human welfare or the industry.
INSIGHTS BY DISTRIBUTION CHANNEL
The global biosafety cabinet market by distribution channels segments as online and offline. The offline method is one of the oldest techniques that are in existence that is utilized to get a company’s products to their potential customer. In 2022, the offline distribution channel had the highest global biosafety cabinet market share. Factors such as broader reach in areas that lack better connectivity and high consumer trust associated with touching and experiencing the quality of products are driving the growth of this segment. Further, the online distribution channel allows manufacturers and vendors to have multichannel campaigns across various channels, such as third-party retailers and direct websites. Online shopping entails online buying, mobile ordering, and digital media. High penetration rates of connectivity are expected to grow the online multichannel platforms' visibility during the forecasted period, thus increasing the online presence of the vendors.
North America holds the largest global biosafety cabinet market share, accounting for over 38% in 2022. The market is majorly driven by the presence of pharmaceutical, research, and development institutes and laboratories for diagnostic purposes. The region of North America majorly consists of developed countries, and the U.S. is the major contributor to their economy. According to Torreya, in 2020, U.S pharmaceutical companies raised USD 120.3 billion in Initial Public Offering, the highest in recent years. Such reasons are projected to propel the growth of biosafety cabinets in the region during the forecasted period.
Europe is one of the most developed regions globally and has many developed nations. The region of Europe has many nations that hold a significant share of pharmaceutical companies. Countries such as Germany, France, and the U.K. have the highest market share in the European region. Germany is the top country in the European region for investments in research and development. Germany also has a huge base of university research centers that assist in research and development nationwide. Across the European region, many projects have been undertaken in the pharmaceutical sector, which further positively impact the development of research laboratories and facilities. These facilities and laboratories would require biosafety cabinets for personnel and environmental protection. Hence indirectly having a positive impact on the growth of the biosafety cabinet market.
The global biosafety cabinet market is moderately fragmented and has many national and international participants. These players have been continuously focusing on innovation and product differentiation techniques. They also rely on these factors to capture higher market shares. It is also expected that with more favorable financial and technological capabilities will be able to invent and launch products that are technologically integrated, which might threaten the products of their competitors and could make their products and services non-competitive. The biosafety cabinet market has a huge number of manufacturers present in the market. Thermo Fisher, Kewaunee Scientific, and Esco Lifesciences Group are some of the dominant players in the global biosafety cabinet market. The major strategies that have been incorporated to ensure their industry share include new product launches, mergers and acquisitions, and acquiring certifications for their biosafety cabinets. Certified products hold a much higher acceptance level as they are guaranteed their performance capability and naturally become more reliant and dependable.
Frequently Asked Questions
How big is the biosafety cabinet market?
The global biosafety cabinet market was valued at USD 265 million in 2022 and is expected to reach USD 405.86 million by 2028.
What is the growth rate of the global biosafety cabinet market?
The global biosafety cabinet market is expected to grow at a CAGR of 7.36% from 2022 to 2028.
Which region dominates the global biosafety cabinet market share?
North America held the most substantial global biosafety cabinet market share and held a share of over 38% in 2022
What are the significant trends in the biosafety cabinet market?
The increased risk of communal diseases, increasing R&D investment in the pharmaceutical and biopharmaceutical industry, and rapid growth in the pharmaceutical sector are significant trends in the biosafety cabinet market.
Who are the key players in the global biosafety cabinet market?
Thermo Fisher, Kewaunee Scientific, and Esco Lifesciences Group are the key players in the global biosafety cabinet market.
The global biosafety cabinet market is expected to grow at a CAGR of approximately 7.36% from 2022 to 2028.
The following factors are likely to contribute to the growth of the biosafety cabinet market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the biosafety cabinet market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Company Profiles
Other Prominent Vendors
Segmentation by Product Type
Segmentation by End-User
Segmentation by Distribution Channel
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT TYPE
4.3.2 MARKET SEGMENTATION BY END-USER
4.3.3 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
6.1.1 GROWTH IN TECHNOLOGICAL ADVANCES
6.1.2 INCREASED RISK OF COMMUNICABLE DISEASES
6.1.3 DEVELOPMENT IN BIOLOGICAL TESTING
6.2 MARKET LANDSCAPE
6.2.1 PRODUCT TYPE
6.2.2 END-USER
6.2.3 COMPETITIVE LANDSCAPE
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
8.2 KEY FACTORS
8.3 BIOSAFETY LEVELS
8.3.1 BIOSAFETY LEVEL 1
8.3.2 BIOSAFETY LEVEL 2
8.3.3 BIOSAFETY LEVEL 3
8.3.4 BIOSAFETY LEVEL 4
9 MARKET OPPORTUNITIES & TRENDS
9.1 INCREASE IN RISK OF COMMUNICABLE DISEASES
9.2 INCREASE IN R&D INVESTMENTS IN PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY
9.3 INCREASE IN REVENUES OF PHARMACEUTICAL COMPANIES
10 MARKET GROWTH ENABLERS
10.1 REGULATION IN PLACE BY ORGANIZATIONS
10.2 RAPID DEVELOPMENT IN BIOLOGICAL TESTING
10.3 RAPID GROWTH IN TECHNOLOGICAL DEVELOPMENT
11 MARKET RESTRAINTS
11.1 FLUCTUATION IN PRICES OF RAW MATERIALS AND SUPPLY CHAIN
11.2 SHORTAGE OF SKILLED LABOR
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CLASS I
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 CLASS II
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.4.4 CLASS II A1
13.4.5 CLASS II A1 MARKET SIZE & FORECAST
13.4.6 CLASS II A1 MARKET BY GEOGRAPHY
13.4.7 CLASS II A2
13.4.8 CLASS II A2 MARKET SIZE & FORECAST
13.4.9 CLASS II A2 MARKET BY GEOGRAPHY
13.4.10 CLASS II B1
13.4.11 CLASS II B1 MARKET SIZE & FORECAST
13.4.12 CLASS II B1 MARKET BY GEOGRAPHY
13.4.13 CLASS II B2
13.4.14 CLASS II B2 MARKET SIZE & FORECAST
13.4.15 CLASS II B2 MARKET BY GEOGRAPHY
13.4.16 CLASS II C1
13.4.17 CLASS II C1 MARKET SIZE & FORECAST
13.4.18 CLASS II C1 MARKET BY GEOGRAPHY
13.5 CLASS III
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
14 END-USER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 DIAGNOSTIC TESTING & LABORATORIES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 ACADEMIC RESEARCH INSTITUTES
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 DISTRIBUTION CHANNEL
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 OFFLINE
15.3.1 MARKET OVERVIEW
15.3.2 DEALERS & DISTRIBUTION
15.3.3 SPECIALTY STORES
15.3.4 MARKET SIZE & FORECAST
15.3.5 MARKET BY GEOGRAPHY
15.4 ONLINE
15.4.1 MARKET OVERVIEW
15.4.2 DIRECT SALES
15.4.3 THIRD-PARTY SALES
15.4.4 MARKET SIZE & FORECAST
15.4.5 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 PRODUCT TYPE
17.3.1 MARKET SIZE & FORECAST
17.4 CLASS II
17.4.1 CLASS II: MARKET SIZE & FORECAST
17.5 END-USER
17.5.1 MARKET SIZE & FORECAST
17.6 DISTRIBUTION CHANNEL
17.6.1 MARKET SIZE & FORECAST
17.7 KEY COUNTRIES
17.7.1 US: MARKET SIZE & FORECAST
17.7.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 PRODUCT TYPE
18.3.1 MARKET SIZE & FORECAST
18.4 CLASS II
18.4.1 CLASS II: MARKET SIZE & FORECAST
18.5 END-USER
18.5.1 MARKET SIZE & FORECAST
18.6 DISTRIBUTION CHANNEL
18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
18.7.1 GERMANY: MARKET SIZE & FORECAST
18.7.2 UK: MARKET SIZE & FORECAST
18.7.3 FRANCE: MARKET SIZE & FORECAST
18.7.4 ITALY: MARKET SIZE & FORECAST
18.7.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 PRODUCT TYPE
19.3.1 MARKET SIZE & FORECAST
19.4 CLASS II
19.4.1 CLASS II: MARKET SIZE & FORECAST
19.5 END-USER
19.5.1 MARKET SIZE & FORECAST
19.6 DISTRIBUTION CHANNEL
19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
19.7.1 CHINA: MARKET SIZE & FORECAST
19.7.2 JAPAN: MARKET SIZE & FORECAST
19.7.3 INDIA: MARKET SIZE & FORECAST
19.7.4 AUSTRALIA: MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 PRODUCT TYPE
20.3.1 MARKET SIZE & FORECAST
20.4 CLASS II
20.4.1 CLASS II: MARKET SIZE & FORECAST
20.5 END-USER
20.5.1 MARKET SIZE & FORECAST
20.6 DISTRIBUTION CHANNEL
20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
20.7.1 SAUDI ARABIA: MARKET SIZE & FORECAST
20.7.2 SOUTH AFRICA: MARKET SIZE & FORECAST
20.7.3 UAE: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 PRODUCT TYPE
21.3.1 MARKET SIZE & FORECAST
21.4 CLASS II
21.4.1 MARKET SIZE & FORECAST
21.5 END-USER
21.5.1 MARKET SIZE & FORECAST
21.6 DISTRIBUTION CHANNEL
21.6.1 MARKET SIZE & FORECAST
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
23 KEY COMPANY PROFILES
23.1 THERMO FISHER
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 KEWAUNEE SCIENTIFIC
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 ESCO LIFESCIENCES GROUP
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 THE BAKER COMPANY
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 AZBIL GROUP
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 NUAIRE
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 LABCONCO
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 GERMFREE LABORATORIES
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 CRUMA
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 SUZHOU ANTAI AIRTECH CO LTD
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 QINGDAO HAIER BIOMEDICAL
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 AIR SCIENCE
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 BERNER INTERNATIONAL
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 CONTAINED AIR SOLUTIONS
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERING
24.12 BIOEVOPEAK
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERING
24.13 PHOTON CLEAN INC
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERING
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 NORTH AMERICA
26.2.1 PRODUCT TYPE: MARKET SIZE & FORECAST
26.2.2 CLASS II: MARKET SIZE & FORECAST
26.2.3 END-USER: MARKET SIZE & FORECAST
26.2.4 DISTRIBUTION CHANNEL: MARKET SIZE & FORECAST
26.3 EUROPE
26.3.1 PRODUCT TYPE: MARKET SIZE & FORECAST
26.3.2 CLASS II: MARKET SIZE & FORECAST
26.3.3 END-USER: MARKET SIZE & FORECAST
26.3.4 DISTRIBUTION CHANNEL: MARKET SIZE & FORECAST
26.4 APAC
26.4.1 PRODUCT TYPE: MARKET SIZE & FORECAST
26.4.2 CLASS II: MARKET SIZE & FORECAST
26.4.3 END-USER: MARKET SIZE & FORECAST
26.4.4 DISTRIBUTION CHANNEL: MARKET SIZE & FORECAST
26.5 MIDDLE EAST & AFRICA
26.5.1 PRODUCT TYPE: MARKET SIZE & FORECAST
26.5.2 CLASS II: MARKET SIZE & FORECAST
26.5.3 END-USER: MARKET SIZE & FORECAST
26.5.4 DISTRIBUTION CHANNEL: MARKET SIZE & FORECAST
26.6 LATIN AMERICA
26.6.1 PRODUCT TYPE: MARKET SIZE & FORECAST
26.6.2 CLASS II: MARKET SIZE & FORECAST
26.6.3 END-USER: MARKET SIZE & FORECAST
26.6.4 DISTRIBUTION CHANNEL: MARKET SIZE & FORECAST
27 APPENDIX
27.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL BIOSAFETY CABINETS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 BIOSAFETY LEVEL STANDARDS
EXHIBIT 4 IMPACT OF INCREASE IN RISK OF COMMUNICABLE DISEASES
EXHIBIT 5 IMPACT OF URBANIZATION ON INFECTIOUS DISEASES
EXHIBIT 6 IMPACT OF INCREASE IN R&D INVESTMENTS IN PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY
EXHIBIT 7 ACTIVITIES COVERED BY R&D
EXHIBIT 8 IMPACT OF INCREASE IN REVENUES OF PHARMACEUTICAL COMPANIES
EXHIBIT 9 PHARMACEUTICAL VALUE-ADDED OUTPUT PER REGION YEAR-ON-YEAR CHANGE (% SHARE)
EXHIBIT 10 IMPACT OF REGULATION IN PLACE BY ORGANIZATIONS
EXHIBIT 11 REGULATIONS FOR R&D FACILITIES AND BIOSAFETY CABINETS
EXHIBIT 12 IMPACT OF RAPID DEVELOPMENT IN BIOLOGICAL TESTING
EXHIBIT 13 SECTORS WHERE BIOLOGICAL TESTING IS CONDUCTED
EXHIBIT 14 NEW ZEALAND LABORATORY ACCREDITATION GUIDELINES
EXHIBIT 15 IMPACT OF RAPID GROWTH IN TECHNOLOGICAL DEVELOPMENT
EXHIBIT 16 TECHNOLOGICAL ADVANCES IN BIOSAFETY CABINETS
EXHIBIT 17 IMPACT OF FLUCTUATION IN PRICES OF RAW MATERIALS AND SUPPLY CHAIN
EXHIBIT 18 SUPPLY CHAIN CHALLENGES
EXHIBIT 19 RAW MATERIALS REQUIRED IN MANUFACTURING PROCESS
EXHIBIT 20 IMPACT OF SHORTAGE OF SKILLED LABOR
EXHIBIT 21 MARKET SHARE OF BIOSAFETY CABINETS 2022
EXHIBIT 22 GLOBAL BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 23 FIVE FORCES ANALYSIS 2022
EXHIBIT 24 INCREMENTAL GROWTH BY PRODUCT TYPE 2022 & 2028
EXHIBIT 25 CLASSIFICATION OF BIOSAFETY CABINETS
EXHIBIT 26 CLASS I BIOSAFETY CABINETS INSIGHTS
EXHIBIT 27 CERTIFICATION OF CLASS I BIOSAFETY CABINETS 2022
EXHIBIT 28 GLOBAL CLASS I BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 29 CLASSIFICATIONS OF CLASS II BIOSAFETY CABINETS BY PRODUCT TYPE
EXHIBIT 30 TESTS CONDUCTED FOR CERTIFICATION OF CLASS II BIOSAFETY CABINETS
EXHIBIT 31 GLOBAL CLASS II BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 32 GLOBAL CLASS II A1 BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 33 GLOBAL CLASS II A2 BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 34 GLOBAL CLASS II B1 BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 35 GLOBAL CLASS II B2 BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 36 GLOBAL CLASS II C1 BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 37 FEATURES OF CLASS III BIOSAFETY CABINETS
EXHIBIT 38 TESTS AND CERTIFICATIONS REQUIRED FOR CLASS III BIOSAFETY CABINETS
EXHIBIT 39 GLOBAL CLASS III BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 40 INCREMENTAL GROWTH BY END-USER 2022 & 2028
EXHIBIT 41 END-USERS OF BIOSAFETY CABINETS
EXHIBIT 42 GLOBAL INVESTMENTS IN R&D BY PHARMA COMPANIES BY 2026 ($ BILLION)
EXHIBIT 43 BIOTECHNOLOGY SECTOR BY COUNTRY 2020 (% SHARE)
EXHIBIT 44 GLOBAL BIOSAFETY CABINETS MARKET BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 2022–2028 ($ MILLION)
EXHIBIT 45 BIOSAFETY CABINETS USED FOR TESTS AT DIAGNOSTIC TESTING & LABORATORIES
EXHIBIT 46 GLOBAL BIOSAFETY CABINETS MARKET BY DIAGNOSTIC TESTING & LABORATORIES 2022–2028 ($ MILLION)
EXHIBIT 47 MANCHESTER UNIVERSITY BIOTECHNOLOGY RESEARCH AND DEVELOPMENT INSIGHTS 2022
EXHIBIT 48 GUIDANCE FOR COLLABORATIONS
EXHIBIT 49 GLOBAL BIOSAFETY CABINETS MARKET BY ACADEMIC RESEARCH INSTITUTES 2022–2028 ($ MILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2022 & 2028
EXHIBIT 51 CLASSIFICATION BY DISTRIBUTION CHANNEL
EXHIBIT 52 CLASSIFICATION OF OFFLINE DISTRIBUTION CHANNELS
EXHIBIT 53 GLOBAL OFFLINE BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 54 CLASSIFICATIONS OF ONLINE DISTRIBUTION CHANNELS
EXHIBIT 55 GLOBAL ONLINE BIOSAFETY CABINETS MARKET 2022–2028 ($ MILLION)
EXHIBIT 56 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 57 MARKET SHARE OF BIOSAFETY CABINETS ACROSS THE GLOBE
EXHIBIT 58 PHARMACEUTICAL STATISTICS OF US
EXHIBIT 59 FIVE PILLAR BIOMANUFACTURING AND LIFE SCIENCES STRATEGY OF CANADA 2021
EXHIBIT 60 BIOSAFETY CABINETS MARKET IN NORTH AMERICA 2022–2028 ($ MILLION)
EXHIBIT 61 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
EXHIBIT 62 TOP MEDICAL INNOVATIONS IN US
EXHIBIT 63 BIOSAFETY CABINETS MARKET IN US 2022–2028 ($ MILLION)
EXHIBIT 64 R&D INVESTMENT ACTIVITIES IN CANADA BY REGION 2019
EXHIBIT 65 REGULATIONS BY GOVERNMENT OF CANADA FOR BIOSAFETY CABINETS USAGE
EXHIBIT 66 BIOSAFETY CABINETS MARKET IN CANADA 2022–2028 ($ MILLION)
EXHIBIT 67 EUROPEAN PHARMACEUTICAL INDUSTRY STATISTICS 2022 ($ MILLION)
EXHIBIT 68 BIOSAFETY CABINETS MARKET IN EUROPE 2022–2028 ($ MILLION)
EXHIBIT 69 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
EXHIBIT 70 MAJOR RESEARCH AREAS OF PHARMACEUTICAL INDUSTRY IN GERMANY
EXHIBIT 71 BIOSAFETY CABINETS MARKET IN FRANCE 2022–2028 ($ MILLION)
EXHIBIT 72 FUNDING FOR R&D IN PHARMACEUTICAL SECTOR IN 2020 (IN MILLION)
EXHIBIT 73 BIOSAFETY CABINETS MARKET IN UK 2022–2028 ($ MILLION)
EXHIBIT 74 BIOSAFETY CABINETS MARKET IN FRANCE 2022–2028 ($ MILLION)
EXHIBIT 75 GROWTH OF PHARMACEUTICAL SECTOR IN ITALY 2019
EXHIBIT 76 BIOSAFETY CABINETS MARKET IN ITALY 2022–2028 ($ MILLION)
EXHIBIT 77 BIOSAFETY CABINETS MARKET IN SPAIN 2022–2028 ($ MILLION)
EXHIBIT 78 NET SPENDING ON HEALTHCARE SECTOR BY REGION 2022 ($ BILLION)
EXHIBIT 79 BIOSAFETY CABINETS MARKET IN APAC 2022–2028 ($ MILLION)
EXHIBIT 80 INCREMENTAL GROWTH IN APAC 2022 & 2028
EXHIBIT 81 REVENUES OF TOP PHARMACEUTICAL COMPANIES IN CHINA 2021
EXHIBIT 82 PROJECTS INITIATED IN 2021
EXHIBIT 83 BIOSAFETY CABINETS MARKET IN CHINA 2022–2028 ($ MILLION)
EXHIBIT 84 BIOSAFETY CABINETS MARKET IN JAPAN 2022–2028 ($ MILLION)
EXHIBIT 85 AREAS OF RESEARCH AT TOKYO UNIVERSITY 2022
EXHIBIT 86 INDIAN PHARMACEUTICAL EXPORTS TO COUNTRIES IN 2021 (IN $ MILLION)
EXHIBIT 87 BIOSAFETY CABINETS MARKET IN INDIA 2022–2028 ($ MILLION)
EXHIBIT 88 INCLUSION IN BIOTECHNOLOGIES IN AUSTRALIA
EXHIBIT 89 ACHIEVEMENTS FROM BIOTECHNOLOGICAL SECTOR IN AUSTRALIA
EXHIBIT 90 BIOSAFETY CABINETS MARKET IN AUSTRALIA 2022–2028 ($ MILLION)
EXHIBIT 91 ESTIMATED SHARE OF BIOSAFETY CABINETS MARKET BY COUNTRY IN MEA IN 2028
EXHIBIT 92 SOUTH AFRICA SPENDING ON PHARMACEUTICALS 2020
EXHIBIT 93 BIOSAFETY CABINETS MARKET IN MIDDLE EAST AND AFRICA 2022–2028 ($ MILLION)
EXHIBIT 94 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028
EXHIBIT 95 BIOSAFETY CABINETS MARKET IN SAUDI ARABIA 2022–2028 ($ MILLION)
EXHIBIT 96 REASONS TO INVEST IN PHARMACEUTICAL SECTOR IN SOUTH AFRICA
EXHIBIT 97 BIOSAFETY CABINETS MARKET IN SOUTH AFRICA 2022–2028 ($ MILLION)
EXHIBIT 98 BIOSAFETY CABINETS MARKET IN UAE 2022–2028 ($ MILLION)
EXHIBIT 99 BIOSAFETY CABINETS MARKET IN LATIN AMERICA 2022–2028 ($ MILLION)
EXHIBIT 100 DISTRIBUTION OF BIO-SAFETY CABINETS MARKET IN LATIN AMERICA 2022
EXHIBIT 101 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
EXHIBIT 102 BIOSAFETY CABINETS MARKET IN BRAZIL 2022–2028 ($ MILLION)
EXHIBIT 103 BIOSAFETY CABINETS MARKET IN MEXICO 2022–2028 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2022
TABLE 3 NUMBER OF INFECTIOUS DISEASES IN US IN 2019
TABLE 4 R&D INVESTMENTS BY TOP PHARMACEUTICAL COMPANIES 2021
TABLE 5 PHARMACEUTICAL OUTPUT IN 2022 ($ MILLION)
TABLE 6 REGULATIONS FOR PRACTICES AND EQUIPMENT REQUIREMENTS FOR VARIOUS LABORATORIES
TABLE 7 GLOBAL CLASS I BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 8 GLOBAL CLASS II BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 9 GLOBAL CLASS II A1 BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 10 GLOBAL CLASS II A2 BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 11 GLOBAL CLASS II B1 BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 12 GLOBAL CLASS II B2 BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 13 GLOBAL CLASS II C1 BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 14 GLOBAL CLASS III BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 15 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 16 GLOBAL DIAGNOSTIC TESTING & LABORATORIES BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 17 COLLABORATIONS OF MONASH UNIVERSITY WITH PHARMACEUTICAL INDUSTRY 2022
TABLE 18 GLOBAL ACADEMIC RESEARCH INSTITUTES BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 19 GLOBAL OFFLINE BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 20 INTERNET PENETRATION IN US BY YEAR
TABLE 21 INTERNET PENETRATION IN US BY AGE
TABLE 22 GLOBAL ONLINE BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 23 BIOSAFETY CABINETS MARKET IN NORTH AMERICA BY PRODUCT TYPE 2022–2028 ($ MILLION)
TABLE 24 BIOSAFETY CABINETS MARKET IN NORTH AMERICA BY CLASS II 2022–2028 ($ MILLION)
TABLE 25 BIOSAFETY CABINETS MARKET IN NORTH AMERICA BY END-USER 2022–2028 ($ MILLION)
TABLE 26 BIOSAFETY CABINETS MARKET IN NORTH AMERICA BY DISTRIBUTION CHANNEL 2022–2028 ($ MILLION)
TABLE 27 EUROPE BIOSAFETY CABINETS MARKET BY PRODUCT TYPE 2022–2028 ($ MILLION)
TABLE 28 EUROPE BIOSAFETY CABINETS MARKET BY CLASS II 2022–2028 ($ MILLION)
TABLE 29 EUROPE BIOSAFETY CABINETS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 30 EUROPE BIOSAFETY CABINETS MARKET BY DISTRIBUTION CHANNEL 2022–2028 ($ MILLION)
TABLE 31 THE UNIVERSITY OF NOTTINGHAM’S COLLABORATIONS WITH PHARMACEUTICAL COMPANIES
TABLE 32 LIST OF AMOUNTS SANCTIONED BY GOVERNMENT OF FRANCE 2021
TABLE 33 SCIENCE PARKS AND INNOVATION HUBS IN ITALY 2022
TABLE 34 APAC BIOSAFETY CABINETS MARKET BY PRODUCT TYPE 2022–2028 ($ MILLION)
TABLE 35 APAC BIOSAFETY CABINETS MARKET BY CLASS II 2022–2028 ($ MILLION)
TABLE 36 APAC BIOSAFETY CABINETS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 37 APAC BIOSAFETY CABINETS MARKET BY DISTRIBUTION CHANNEL 2022–2028 ($ MILLION)
TABLE 38 MEA BIOSAFETY CABINETS MARKET BY PRODUCT TYPE 2022–2028 ($ MILLION)
TABLE 39 MEA BIOSAFETY CABINETS MARKET BY CLASS II 2022–2028 ($ MILLION)
TABLE 40 MEA BIOSAFETY CABINETS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 41 MEA BIOSAFETY CABINETS MARKET BY DISTRIBUTION CHANNEL 2022–2028 ($ MILLION)
TABLE 42 LATIN AMERICA BIOSAFETY CABINETS MARKET BY PRODUCT TYPE 2022–2028 ($ MILLION)
TABLE 43 LATIN AMERICA BIOSAFETY CABINETS MARKET BY CLASS II 2022–2028 ($ MILLION)
TABLE 44 LATIN AMERICA BIOSAFETY CABINETS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 45 LATIN AMERICA BIOSAFETY CABINETS MARKET BY DISTRIBUTION CHANNEL 2022–2028 ($ MILLION)
TABLE 46 THERMO FISHER: MAJOR PRODUCT OFFERINGS
TABLE 47 KEWAUNEE SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 48 ESCO LIFESCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 49 THE BAKER COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 50 AZBIL GROUP: MAJOR PRODUCT OFFERINGS
TABLE 51 NUAIRE: MAJOR PRODUCT OFFERINGS
TABLE 52 LABCONCO: MAJOR PRODUCT OFFERINGS
TABLE 53 GERMFREE LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 54 CRUMA: MAJOR PRODUCT OFFERINGS
TABLE 55 SUZHOU ANTAI AIRTECH CO LTD: MAJOR PRODUCT OFFERINGS
TABLE 56 QINGDAO HAIER BIOMEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 57 AIR SCIENCE: MAJOR PRODUCT OFFERINGS
TABLE 58 BERNER INTERNATIONAL: MAJOR PRODUCT OFFERINGS
TABLE 59 CONTAINED AIR SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 60 BIOEVOPEAK: MAJOR PRODUCT OFFERINGS
TABLE 61 PHOTON CLEAN INC: MAJOR PRODUCT OFFERINGS
TABLE 62 GLOBAL BIOSAFETY CABINETS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 63 BIOSAFETY CABINETS MARKET IN NORTH AMERICA BY PRODUCT TYPE 2022–2028 ($ MILLION)
TABLE 64 BIOSAFETY CABINETS MARKET IN NORTH AMERICA BY CLASS II 2022–2028 ($ MILLION)
TABLE 65 BIOSAFETY CABINETS MARKET IN NORTH AMERICA BY END-USER 2022–2028 ($ MILLION)
TABLE 66 BIOSAFETY CABINETS MARKET IN NORTH AMERICA BY DISTRIBUTION CHANNEL 2022–2028 ($ MILLION)
TABLE 67 BIOSAFETY CABINETS MARKET IN EUROPE BY PRODUCT TYPE 2022–2028 ($ MILLION)
TABLE 68 BIOSAFETY CABINETS MARKET IN EUROPE BY CLASS II 2022–2028 ($ MILLION)
TABLE 69 BIOSAFETY CABINETS MARKET IN EUROPE BY END-USER 2022–2028 ($ MILLION)
TABLE 70 BIOSAFETY CABINETS MARKET IN EUROPE BY DISTRIBUTION CHANNEL 2022–2028 ($ MILLION)
TABLE 71 BIOSAFETY CABINETS MARKET IN APAC BY PRODUCT TYPE 2022–2028 ($ MILLION)
TABLE 72 BIOSAFETY CABINETS MARKET IN APAC BY CLASS II 2022–2028 ($ MILLION)
TABLE 73 BIOSAFETY CABINETS MARKET IN APAC BY END-USER 2022–2028 ($ MILLION)
TABLE 74 BIOSAFETY CABINETS MARKET IN APAC BY DISTRIBUTION CHANNEL 2022–2028 ($ MILLION)
TABLE 75 BIOSAFETY CABINETS MARKET IN MEA BY PRODUCT TYPE 2022–2028 ($ MILLION)
TABLE 76 BIOSAFETY CABINETS MARKET IN MEA BY CLASS II 2022–2028 ($ MILLION)
TABLE 77 BIOSAFETY CABINETS MARKET IN MEA BY END-USER 2022–2028 ($ MILLION)
TABLE 78 BIOSAFETY CABINETS MARKET IN MEA BY DISTRIBUTION CHANNEL 2022–2028 ($ MILLION)
TABLE 79 BIOSAFETY CABINETS MARKET IN LATIN AMERICA BY PRODUCT TYPE 2022–2028 ($ MILLION)
TABLE 80 BIOSAFETY CABINETS MARKET IN LATIN AMERICA BY CLASS II 2022–2028 ($ MILLION)
TABLE 81 BIOSAFETY CABINETS MARKET IN LATIN AMERICA BY END-USER 2022–2028 ($ MILLION)
TABLE 82 BIOSAFETY CABINETS MARKET IN LATIN AMERICA BY DISTRIBUTION CHANNEL 2022–2028 ($ MILLION)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
